CN101723942A - 酰亚胺类衍生物的制备方法 - Google Patents
酰亚胺类衍生物的制备方法 Download PDFInfo
- Publication number
- CN101723942A CN101723942A CN200810167903A CN200810167903A CN101723942A CN 101723942 A CN101723942 A CN 101723942A CN 200810167903 A CN200810167903 A CN 200810167903A CN 200810167903 A CN200810167903 A CN 200810167903A CN 101723942 A CN101723942 A CN 101723942A
- Authority
- CN
- China
- Prior art keywords
- formula
- preparation
- solvent
- imide derivatives
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810167903 CN101723942B (zh) | 2008-10-16 | 2008-10-16 | 酰亚胺类衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810167903 CN101723942B (zh) | 2008-10-16 | 2008-10-16 | 酰亚胺类衍生物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101723942A true CN101723942A (zh) | 2010-06-09 |
CN101723942B CN101723942B (zh) | 2012-07-18 |
Family
ID=42445562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810167903 Active CN101723942B (zh) | 2008-10-16 | 2008-10-16 | 酰亚胺类衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101723942B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669665A (zh) * | 2016-03-15 | 2016-06-15 | 烟台贝森医药科技有限公司 | 哌罗匹隆的制备方法 |
CN112225732A (zh) * | 2019-07-15 | 2021-01-15 | 四川科瑞德制药股份有限公司 | 一种新的盐酸哌罗匹隆水合物晶型及其制备方法 |
CN114031574A (zh) * | 2021-11-08 | 2022-02-11 | 复旦大学附属肿瘤医院 | 哌罗匹隆及其衍生物在制备抗肿瘤药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0625181B2 (ja) * | 1985-03-27 | 1994-04-06 | 住友製薬株式会社 | 新規なイミド誘導体 |
-
2008
- 2008-10-16 CN CN 200810167903 patent/CN101723942B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669665A (zh) * | 2016-03-15 | 2016-06-15 | 烟台贝森医药科技有限公司 | 哌罗匹隆的制备方法 |
CN112225732A (zh) * | 2019-07-15 | 2021-01-15 | 四川科瑞德制药股份有限公司 | 一种新的盐酸哌罗匹隆水合物晶型及其制备方法 |
CN112225732B (zh) * | 2019-07-15 | 2024-01-09 | 四川科瑞德制药股份有限公司 | 一种盐酸哌罗匹隆水合物晶型及其制备方法 |
CN114031574A (zh) * | 2021-11-08 | 2022-02-11 | 复旦大学附属肿瘤医院 | 哌罗匹隆及其衍生物在制备抗肿瘤药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101723942B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brown et al. | Triazole oxytocin antagonists: identification of an aryloxyazetidine replacement for a biaryl substituent | |
Anderson et al. | Pyrido [2, 3-d] pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors | |
US9856215B2 (en) | Preparation method of Nintedanib | |
IE58338B1 (en) | Pyrimidinyl-piperazine derivatives | |
CN102241667B (zh) | 1-[(4-羟基哌啶-4基)甲基]吡啶-2(1h)-酮衍生物及其制备方法和用途 | |
Peprah et al. | Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents | |
JP2008523031A (ja) | 部分的ドーパミン−d2受容体作動性とセロトニン再摂取阻害の組み合わせを示すフェニルピペラジン誘導体 | |
CN101723942B (zh) | 酰亚胺类衍生物的制备方法 | |
CN105085383B (zh) | 5‑甲基‑2(1h)吡啶酮衍生物及其制备方法和用途 | |
CN102690225B (zh) | 巴多昔芬的合成方法 | |
CN104447620B (zh) | 1-[3-[3-(4-氯苯基)丙氧基]丙基]-哌啶盐酸盐的制备方法 | |
Bode et al. | Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors | |
CN103649019A (zh) | 用于治疗精神***症的氘化的1-哌嗪子基-3-苯基-茚满 | |
TW401417B (en) | 4-Aryloxy- and 4-arylthiopiperidine derivatives | |
Du et al. | Imidazo-pyrazine derivatives as potent CXCR3 antagonists | |
CN104974105A (zh) | 一种制备4-(4-氨基苯基)-3-吗啉酮的方法 | |
CN105130884B (zh) | 5‑甲基‑2(1h)吡啶酮衍生物及其制备方法和用途 | |
CA2346896C (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders | |
Bannwart et al. | Novel 3, 3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors | |
EP0123962B1 (en) | Benzimidazole derivative, process for the preparation thereof and pharmaceutical composition | |
CN107365301B (zh) | 一种克唑替尼的合成方法及其中间体制备方法 | |
EP2810942B1 (en) | Paroxetine derivative | |
McBride et al. | 3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors | |
CN101243075A (zh) | 新颖的2,3-二氢吲哚化合物 | |
Bollinger et al. | Synthesis and structure–activity relationships of a series of 4-methoxy-3-(piperidin-4-yl) oxy benzamides as novel inhibitors of the presynaptic choline transporter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHUZHOU BONDED ZONE LIZHU SYNTHETIC PHARMACEUTICAL Free format text: FORMER OWNER: LIZHU MEDICINE GROUP CO., LTD. Effective date: 20140415 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 519020 ZHUHAI, GUANGDONG PROVINCE TO: 519030 ZHUHAI, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140415 Address after: 519030 Zhuhai Special Economic Zone, Guangdong, Zhuhai Free Trade Zone, Wan Chai Patentee after: Zhuzhou Bonded Zone Lizhu Synthetic Pharmaceutical Co., Ltd. Address before: 519020, Zhuhai Special Economic Zone, Guangdong, Gongbei Osmanthus Road No. 132 Patentee before: Lizhu Medicine Group Co., Ltd. |